Get the Stockscreener App
0.21
5.41%
-0.012
After Hours:
.22
0.01
+4.76%
T 2 Biosystems Inc stock is traded at $0.21, with a volume of 1.79M.
It is down -5.41% in the last 24 hours and down -48.78% over the past month.
T2 Biosystems Inc is a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes. It is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. The company's products include the T2Dx Instrument, the T2Bacteria Panel, the T2Candida Panel, the T2Resistance Panel, and the T2Biothreat Panel, and are powered by the proprietary T2 Magnetic Resonance technology.
See More
Previous Close:
$0.222
Open:
$0.225
24h Volume:
1.79M
Relative Volume:
1.74
Market Cap:
$5.89M
Revenue:
$7.68M
Net Income/Loss:
$-42.95M
P/E Ratio:
-0.0327
EPS:
-6.4178
Net Cash Flow:
$-36.59M
1W Performance:
+0.00%
1M Performance:
-48.78%
6M Performance:
-94.99%
1Y Performance:
-95.26%
1-Day Range:
$0.2056
$0.229
1-Week Range:
$0.2015
$0.24
52-Week Range:
$0.2015
$6.95
T 2 Biosystems Inc Stock (TTOO) Company Profile
Name
T 2 Biosystems Inc
Sector
Industry
Phone
781-457-1200
Address
101 HARTWELL AVENUE, LEXINGTON
Compare TTOO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TTOO
T 2 Biosystems Inc
|
0.21 | 5.89M | 7.68M | -42.95M | -36.59M | -6.4178 |
|
TMO
Thermo Fisher Scientific Inc
|
572.71 | 219.06B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
210.01 | 151.02B | 23.88B | 3.90B | 5.30B | 5.28 |
|
A
Agilent Technologies Inc
|
147.64 | 42.12B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
209.96 | 38.11B | 15.32B | 1.41B | 1.96B | 7.62 |
|
IDXX
Idexx Laboratories Inc
|
460.56 | 37.71B | 3.84B | 866.24M | 792.60M | 10.37 |
T 2 Biosystems Inc Stock (TTOO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-27-21 | Downgrade | Alliance Global Partners | Buy → Neutral |
| Oct-08-20 | Initiated | BTIG Research | Buy |
| Nov-26-19 | Downgrade | Janney | Buy → Neutral |
| Aug-01-19 | Downgrade | Alliance Global Partners | Buy → Neutral |
| Jul-31-19 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jul-31-19 | Downgrade | Janney | Buy → Neutral |
| May-16-19 | Initiated | Alliance Global Partners | Buy |
| Mar-08-19 | Reiterated | H.C. Wainwright | Buy |
| Jun-01-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
| May-30-18 | Reiterated | H.C. Wainwright | Buy |
| May-29-18 | Reiterated | WBB Securities | Strong Buy |
| Mar-29-18 | Reiterated | H.C. Wainwright | Buy |
| Jan-29-18 | Initiated | Goldman | Neutral |
| Oct-18-17 | Initiated | H.C. Wainwright | Buy |
| Mar-15-17 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Nov-10-16 | Resumed | Leerink Partners | Mkt Perform |
| Nov-02-16 | Reiterated | Cantor Fitzgerald | Buy |
| Jul-20-16 | Upgrade | WBB Securities | Buy → Strong Buy |
| Jun-22-16 | Upgrade | WBB Securities | Speculative Buy → Buy |
| Apr-12-16 | Reiterated | Canaccord Genuity | Buy |
| Feb-17-16 | Initiated | WBB Securities | Speculative Buy |
View All
T 2 Biosystems Inc Stock (TTOO) Latest News
A significant driver of top-line growth: T2 Biosystems Inc (TTOO) - SETE News
Navigating the Volatility of T2 Biosystems Inc’s (TTOO) Stock - The News Heater
Is T2 Biosystems Inc (TTOO) a good investment opportunity? - US Post News
Analyzing the Impact of Earnings Reports on T2 Biosystems Inc Inc. (TTOO) Price Performance - The InvestChronicle
Trading Day Triumph: T2 Biosystems Inc (TTOO) Ends at 0.22, a 2.38 Surge/Plunge - The Dwinnex
T2 Biosystems, Inc. (NASDAQ:TTOO) Short Interest Update - Defense World
T2 Biosystems stock plunges to 52-week low of $0.22 - Investing.com
T2 Biosystems (NASDAQ:TTOO) Coverage Initiated at StockNews.com - Defense World
T2 Biosystems stock plunges to 52-week low of $0.25 - MSN
T2 Biosystems amends loan terms, extends maturity date - MSN
T2 Biosystems (NASDAQ:TTOO) Coverage Initiated by Analysts at StockNews.com - Defense World
T2 Biosystems (NASDAQ:TTOO) Enters into Amendment with CRG Servicing LLCOn January 16, 2025, T2 Biosystems, Inc. announced that it has entered into Amendment No. 12 to its Term Loan Agreement with CRG Servicing LLC as administrative agent an - Defense World
T2 Biosystems amends loan terms, extends maturity date By Investing.com - Investing.com Australia
T2 Biosystems Inc (TTOO): An Important Analyst Insights - Stocks Register
TTOO Stock Forecast: T2, A Zero To Hero Or No Hope For Buyers? - The Market Periodical
T2 Biosystems stock plunges to 52-week low of $0.31 By Investing.com - Investing.com Canada
T2 Biosystems stock plunges to 52-week low of $0.31 - Investing.com India
T2 Biosystems (NASDAQ:TTOO) Now Covered by StockNews.com - Defense World
T2 Biosystems Reports Strong Financial Performance and Strategic Developments - Defense World
T2 Biosystems inks distribution agreement in Baltic region - LabPulse
T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2024 Financial Results - The Manila Times
T2 Biosystems Achieves Record Revenue Growth, Expands Global Reach with 27 New Instrument Contracts - StockTitan
T2 Biosystems announces board changes and incentive plan approval - Investing.com India
T2 Biosystems announces board changes and incentive plan approval By Investing.com - Investing.com South Africa
T2 Biosystems (NASDAQ:TTOO) Now Covered by Analysts at StockNews.com - Defense World
T2 Biosystems Announces Amendments and Voting Results from Annual Meeting**Lexington, Massachusetts – T2 Biosystems, Inc. (NASDAQ: TTOO) recently disclosed significant updates from its recent Annual Meeting with stockholders held on December 3 - Defense World
T2 Biosystems Enhances Governance and Leadership Stability - MSN
T2 Biosystems sells four T2Dx Instruments to European distributor - MSN
T2 Biosystems expands EU presence with instrument sales By Investing.com - Investing.com Australia
Before You Invest, Make Sure You Check This T2 Biosystems Inc (NASDAQ: TTOO) Analysis - Stocks Register
T2 Biosystems Announces Sale of Four T2Dx Instruments to Existing European Distributor - citybiz
T2 Biosystems Expands International Market Presence with Sale of Four T2Dx® Instruments to European Distributor - Nasdaq
T2 Biosystems expands EU presence with instrument sales - Investing.com
T2 Biosystems Expands European Footprint with Strategic T2Dx Instrument Sales, Breakthrough Clinical Data - StockTitan
T2 Biosystems Achieves Key Milestone with 250,000th Novel Sepsis Test Shipped Globally - The Manila Times
T2 Biosystems' Revolutionary Sepsis Tests Hit 250K Milestone, Slash Detection Time by 77 Hours - StockTitan
T2 Biosystems extends Vizient supplier agreement By Investing.com - Investing.com Canada
T 2 Biosystems Inc Stock (TTOO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.51%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):